ERNA vs GRMN · P/E 0.0, rev $582.0K vs P/E 28, rev $6.30B
Eterna Therapeutics Inc (ERNA) versus Garmin Ltd (GRMN) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported GRMN revenue for 2024-12-28 was $6.30B. Net income was $1.41B. Revenue was up 20.4% from 2023-12-30 to 2024-12-28. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Not investment advice. Open the ERNA and GRMN stock pages for the full models.
Not investment advice.